Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 5.17%268.08K | 0.19%215.44K | 0.19%215.44K | -39.72%115.94K | 34.91%255.07K | 29.65%254.91K | -5.82%215.03K | -5.82%215.03K | -49.89%192.32K | 14.38%189.07K |
| -Cash and cash equivalents | 47.45%61.82K | 65.37%122.46K | 65.37%122.46K | -47.71%34.5K | -58.80%33.18K | -56.77%41.92K | -28.96%74.05K | -28.96%74.05K | -73.31%65.98K | 43.00%80.54K |
| -Short term investments | -3.16%206.26K | -34.05%92.98K | -34.05%92.98K | -35.54%81.44K | 104.45%221.89K | 113.79%212.98K | 13.63%140.98K | 13.63%140.98K | -7.46%126.34K | -0.42%108.53K |
| Receivables | -50.29%4.88K | 143.57%11.83K | 143.57%11.83K | -71.69%4.92K | -47.21%6.55K | 78.21%9.81K | -0.49%4.86K | -0.49%4.86K | 54.47%17.39K | 107.74%12.4K |
| -Taxes receivable | -50.29%4.88K | 143.57%11.83K | 143.57%11.83K | -71.69%4.92K | -47.21%6.55K | 78.21%9.81K | -0.49%4.86K | -0.49%4.86K | 54.47%17.39K | 107.74%12.4K |
| Prepaid assets | 0.00%362 | 0.00%362 | 0.00%362 | 0.00%362 | 0.00%362 | -15.62%362 | -15.62%362 | -15.62%362 | -15.42%362 | -15.62%362 |
| Total current assets | 3.11%273.32K | 3.35%227.63K | 3.35%227.63K | -42.29%121.22K | 29.80%261.98K | 30.87%265.08K | -5.72%220.25K | -5.72%220.25K | -46.88%210.07K | 17.55%201.84K |
| Non current assets | ||||||||||
| Net PPE | 1.03%1.9M | 1.03%1.9M | 1.03%1.9M | -0.06%1.89M | -0.06%1.89M | -0.32%1.88M | -0.72%1.88M | -0.72%1.88M | 0.36%1.89M | 0.36%1.89M |
| Total non current assets | 1.03%1.9M | 1.03%1.9M | 1.03%1.9M | -0.06%1.89M | -0.06%1.89M | -0.32%1.88M | -0.72%1.88M | -0.72%1.88M | 0.36%1.89M | 0.36%1.89M |
| Total assets | 1.29%2.17M | 1.28%2.12M | 1.28%2.12M | -4.27%2.01M | 2.83%2.15M | 2.70%2.15M | -1.27%2.1M | -1.27%2.1M | -7.83%2.1M | 1.80%2.09M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current debt and capital lease obligation | --163.87K | 15.70%162.56K | 15.70%162.56K | --5K | --143.13K | ---- | --140.5K | --140.5K | ---- | ---- |
| -Current debt | --163.87K | 15.70%162.56K | 15.70%162.56K | --5K | --143.13K | ---- | --140.5K | --140.5K | ---- | ---- |
| Payables | -9.67%736.46K | -5.10%696.54K | -5.10%696.54K | 66.43%1.05M | 77.39%943.93K | 102.75%815.3K | 134.22%733.95K | 134.22%733.95K | 81.68%628.85K | 117.99%532.13K |
| -accounts payable | -9.67%736.46K | -5.10%696.54K | -5.10%696.54K | 66.43%1.05M | 77.39%943.93K | 102.75%815.3K | 134.22%733.95K | 134.22%733.95K | 81.68%628.85K | 117.99%532.13K |
| Current accrued expenses | 1.24%78.08K | 1.24%78.08K | 1.24%78.08K | 52.92%52.12K | 51.86%51.75K | 42.59%77.12K | 42.59%77.12K | 42.59%77.12K | 235.50%34.08K | 235.50%34.08K |
| Current liabilities | 9.64%978.41K | -1.51%937.18K | -1.51%937.18K | 66.49%1.1M | 101.13%1.14M | 95.62%892.42K | 158.98%951.57K | 158.98%951.57K | 32.68%662.93K | 42.74%566.21K |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | 153.65%359.72K | --349.72K | --349.72K | 15.54%144.44K | ---- | 15.87%141.82K | ---- | ---- | --125.02K | --123.7K |
| -Long term debt | 153.65%359.72K | --349.72K | --349.72K | 15.54%144.44K | ---- | 15.87%141.82K | ---- | ---- | --125.02K | --123.7K |
| Total non current liabilities | 153.65%359.72K | --349.72K | --349.72K | 15.54%144.44K | --0 | 15.87%141.82K | --0 | --0 | --125.02K | --123.7K |
| Total liabilities | 29.38%1.34M | 35.24%1.29M | 35.24%1.29M | 58.41%1.25M | 65.07%1.14M | 78.75%1.03M | 94.79%951.57K | 94.79%951.57K | 57.70%787.94K | 73.93%689.91K |
| Shareholders'equity | ||||||||||
| Share capital | 0.15%20.02M | 0.15%20.02M | 0.15%20.02M | 0.00%19.99M | 0.00%19.99M | 0.00%19.99M | 0.00%19.99M | 0.00%19.99M | 0.24%19.99M | 0.60%19.99M |
| -common stock | 0.15%20.02M | 0.15%20.02M | 0.15%20.02M | 0.00%19.99M | 0.00%19.99M | 0.00%19.99M | 0.00%19.99M | 0.00%19.99M | 0.24%19.99M | 0.60%19.99M |
| Retained earnings | -2.23%-23.32M | -2.20%-23.2M | -2.20%-23.2M | -2.24%-23.03M | -2.58%-22.92M | -2.63%-22.81M | -2.62%-22.7M | -2.62%-22.7M | -2.59%-22.52M | -2.32%-22.34M |
| Gains losses not affecting retained earnings | -93.13%270.14K | 7.29%156.86K | 7.29%156.86K | -97.75%86.66K | -93.95%227.11K | 4.96%3.93M | 13.08%146.21K | 13.08%146.21K | 1.44%3.85M | 3.60%3.76M |
| Other equity interest | --3.86M | 4.03%3.86M | 4.03%3.86M | --3.71M | --3.71M | ---- | 1.99%3.71M | 1.99%3.71M | ---- | ---- |
| Total stockholders'equity | -24.86%834.78K | -26.94%836.72K | -26.94%836.72K | -41.82%765.45K | -27.81%1.01M | -26.43%1.11M | -29.97%1.15M | -29.97%1.15M | -26.19%1.32M | -15.46%1.4M |
| Total equity | -24.86%834.78K | -26.94%836.72K | -26.94%836.72K | -41.82%765.45K | -27.81%1.01M | -26.43%1.11M | -29.97%1.15M | -29.97%1.15M | -26.19%1.32M | -15.46%1.4M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.